Max Healthcare Institute (MAXHEALTH) — Board Meeting

The board recommended a final dividend of ₹1.50 per share (15% of face value) for FY2024-25, subject to shareholder approval at the 24th AGM scheduled for July 30, 2025 via video conference. The record date is set for July 4, 2025, determining eligible shareholders for dividend payout. A detailed communication regarding tax deduction at source (TDS) on dividends has been sent to all members, outlining documentation requirements for TDS exemptions, including Forms 15G/15H, PAN details, and self-declarations based on residency status. The TDS rates vary from 10% to 30% depending on residency and documentation compliance, with higher rates applying if PAN is inoperative or documents are missing. The company emphasized strict deadlines for submitting documents by July 10, 2025, to ensure accurate TDS calculation and dividend processing.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this board meeting affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 24 June 2025?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 24 June 2025

AXISBANK Axis Bank Limited Corporate Action BANKBARODA Bank of Baroda Financial Results SHRIRAMFIN Shriram Finance Limited Annual Report SHRIRAMFIN Shriram Finance Limited Annual Report TECHM Tech Mahindra Limited Annual Report CANBK Canara Bank Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.